PRESENTATION

Q4 FY2024 — Presentation

Q4 FY2024PDF · 17 pages724 KB
Fiscal Year 2024, Fourth Quarter
May 24, 2024
EARNINGS CALL
PRESENTATION

-- 1 of 17 --

2
HORACIO ROZANSKI
President and Chief Executive Officer
MATT CALDERONE
Chief Financial Officer
NATHAN RUTLEDGE
Director & Head of Investor Relations
CALL
PARTICIPANTS

-- 2 of 17 --

3
DISCLAIMER
Forward Looking Safe Harbor Statement
Certain statements contained in this presentation and in related comments by our management include “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. Examples of forward-looking statements include information concerning Booz Allen’s preliminary financial results, financial outlook and guidance, including
forecasted revenue, Adjusted EBITDA, Diluted EPS, Adjusted Diluted EPS, future quarterly dividends, and future improvements in operating margins, as well as any other statement that
does not directly relate to any historical or current fact. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “forecasts,”
“expects,” “intends,” “plans,” “anticipates,” “projects,” “outlook,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “preliminary,” or the negative of these terms or other
comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will
prove to have been correct.
These forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our
actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these
forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in or implied by these forward-looking statements,
including those factors discussed in our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2024,
which can be found at the SEC’s website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the
foregoing cautionary statements. All such statements speak only as of the date made and, except as required by law, we undertake no obligation to update or revise publicly any forward-
looking statements, whether as a result of new information, future events or otherwise.
Note Regarding Non-GAAP Financial Data Information
Booz Allen discloses Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue,
Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio, which are not recognized measurements
under accounting principles generally accepted in the United States, or GAAP, and when analyzing Booz Allen’s performance or liquidity, as applicable, investors should (i) evaluate each
adjustment in our reconciliation of revenue to Revenue, Excluding Billable Expenses, operating income to Adjusted Operating Income, net income attributable to common stockholders to
Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income and Adjusted Diluted EPS, and net cash
provided by operating activities to Free Cash Flow and Free Cash Flow Conversion, and net debt to Net Leverage Ratio and the explanatory footnotes regarding those adjustments, each as
defined under GAAP, (ii) use Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on
Revenue, Excluding Billable Expenses, Adjusted Net Income, and Adjusted Diluted EPS in addition to, and not as an alternative to, revenue, operating income, net income attributable to
common stockholders or diluted EPS, as measures of operating results, each as defined under GAAP, (iii) use Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio, in
addition to, and not as an alternative to, net cash provided by operating activities as a measure of liquidity, each as defined under GAAP, and (iv) use Net Leverage Ratio in addition to, and
not as an alternative to, net debt as a measure of Booz Allen's debt leverage. The Appendix includes a reconciliation of Revenue, Excluding Billable Expenses, Adjusted Operating Income,
Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free
Cash Flow Conversion, and Net Leverage Ratio to the most directly comparable financial measure calculated and presented in accordance with GAAP. Booz Allen presents these
supplemental performance measures because it believes that these measures provide investors and securities analysts with important supplemental information with which to evaluate
Booz Allen’s performance, long term earnings potential, or liquidity, as applicable, and to enable them to assess Booz Allen’s performance on the same basis as management. These
supplemental performance and liquidity measurements may vary from and may not be comparable to similarly titled measures by other companies in Booz Allen’s industry. With respect
to our expectations under “Financial Outlook”, reconciliation of Adjusted Diluted EPS guidance, Adjusted EBITDA, and Adjusted EBITDA Margin on Revenue to the closest corresponding
GAAP measure is not available without unreasonable efforts on a forward-looking basis due to our inability to predict our stock price, equity grants and dividend declarations with respect
to Adjusted Diluted EPS, and our net income, net interest and other expenses with respect to Adjusted EBITDA and Adjusted EBITDA Margin on Revenue, during the course of fiscal 2025.
With respect to Adjusted Diluted EPS guidance, projecting future stock price, equity grants and dividends to be declared would be necessary to accurately calculate the difference between
Adjusted Diluted EPS and GAAP EPS as a result of the effects of the two-class method and related possible dilution used in the calculation of EPS. Consequently, any attempt to disclose
such reconciliation would imply a degree of precision that could be confusing or misleading to investors. We expect the variability of the above charges to have an unpredictable, and
potentially significant, impact on our future GAAP financial results. For the same reason, a reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue guidance for fiscal
2025 and of Adjusted EBITDA guidance through fiscal 2025 to the closest corresponding GAAP measures are not available without unreasonable efforts on a forward-looking basis due to
our inability to predict specific quantifications of the amounts that would be required to reconcile such measures. Accordingly, Booz Allen is relying on the exception provided by Item
10(e)(1)(i)(B) of Regulation S-K to exclude these reconciliations.

-- 3 of 17 --

4
KEY FINANCIAL RESULTS
FISCAL YEAR 2024 RESULTS
(1) Comparisons are to prior fiscal year period.
(2) Reconciliations of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue can be found on Slide 12. Net income attributable to common stockholders was $128.0 million and $605.7 million for the three and twelve months ended
March 31, 2024, respectively. Net income margin attributable to common stockholders was 4.6% and 5.7% for the three and twelve months ended March 31, 2024, respectively.
FOURTH QUARTER (1) FISCAL YEAR 2024 (1)
Revenue $2.8 billion +13.9% $10.7 billion +15.2%
Revenue, Excluding Billable Expenses $1.9 billion +13.7% $7.4 billion +14.4%
Net Income $128 million +287.2% $606 million +123.3%
Adjusted EBITDA2 $287 million +23.9% $1,175 million +15.9%
Adjusted EBITDA Margin on Revenue2 10.3% +8.4% 11.0% —%
Adjusted Net Income $172 million +28.8% $719 million +18.8%
Diluted EPS $0.98 +288.5% $4.59 +126.1%
Adjusted Diluted EPS $1.33 +31.7% $5.50 +20.6%
Net Cash Provided by Operating Activities $144 million (39.4)% $259 million (57.1)%

-- 4 of 17 --

INVESTMENT THESIS
EXCEPTIONAL SHAREHOLDER VALUE CREATION
FY2023–FY2025 GOALS
Competitive
Edge at the
Mission-
Innovation
Intersection
ADJUSTED EBITDA
GROWTH TO $1.2–1.3B
Disciplined
Capital
Deployment
$2.0–3.5B
Organic
Revenue
5–8%
Strategic
Acquisitions &
Investments
Strong Mid 10%
Adjusted
EBITDA Margin
+ +

-- 5 of 17 --

6
KEY FINANCIAL RESULTS
FISCAL YEAR 2024 RESULTS
FOURTH QUARTER (1) FISCAL YEAR 2024 (1)
Revenue $2.8 billion +13.9% $10.7 billion +15.2%
Revenue, Excluding Billable Expenses $1.9 billion +13.7% $7.4 billion +14.4%
Net Income $128 million +287.2% $606 million +123.3%
Adjusted EBITDA2 $287 million +23.9% $1,175 million +15.9%
Adjusted EBITDA Margin on Revenue2 10.3% +8.4% 11.0% —%
Adjusted Net Income $172 million +28.8% $719 million +18.8%
Diluted EPS $0.98 +288.5% $4.59 +126.1%
Adjusted Diluted EPS $1.33 +31.7% $5.50 +20.6%
Net Cash Provided by Operating Activities $144 million (39.4)% $259 million (57.1)%
Page 4 intentionally repeated
(1) Comparisons are to prior fiscal year period.
(2) Reconciliations of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue can be found on Slide 12. Net income attributable to common stockholders was $128.0 million and $605.7 million for the three and twelve months ended
March 31, 2024, respectively. Net income margin attributable to common stockholders was 4.6% and 5.7% for the three and twelve months ended March 31, 2024, respectively.

-- 6 of 17 --

7
$22.0
HISTORICAL BACKLOG & BOOK-TO-BILL
(1) For more information on the components of backlog, and the differences between backlog and remaining performance obligations, please see the Company's Form 10-K for the fiscal year ended March 31, 2024; totals may not sum due to rounding.
BACKLOG ($ IN BILLIONS) (1)
BOOK-TO-BILL TRENDS
$26.8 $29.0 	$27.8 	$29.2 	$28.6
$31.8 $30.0 	$31.2 	$31.3
$35.0 	$34.3 	$33.8
$3.5 	$4.9 	$4.0 	$3.7 	$4.0 	$5.5 	$4.5 	$4.6 	$4.9 	$6.3 	$5.2 	$4.8
$9.0 	$9.5 	$9.4 	$9.9 	$10.0 	$10.4 	$10.1 	$9.5 	$9.0 $10.1 	$9.2 	$9.5
$14.3 $14.6 	$14.3 	$15.6 	$14.6 $16.0 	$15.4 	$17.1 	$17.3
$18.6 	$19.9 	$19.5
Funded 	Unfunded 	Priced Options
1Q22 	2Q22 	3Q22 	4Q22 	1Q23 	2Q23 	3Q23 	4Q23 	1Q24 	2Q24 	3Q24 	4Q24
1.30x
2.03x
0.39x
1.66x
0.72x
2.40x
0.09x
1.47x
1.03x
2.41x
0.72x
0.82x
1.20x 	1.28x
1.28x
1.36x
1.21x 	1.32x 	1.22x
1.18x
1.24x 	1.29x 1.41x 1.25x
Quarterly Book-to-Bill 	LTM Book-to-Bill
1Q22 	2Q22 	3Q22 	4Q22 	1Q23 	2Q23 	3Q23 	4Q23 	1Q24 	2Q24 	3Q24 	4Q24
0.0x
1.0x
2.0x
3.0x

-- 7 of 17 --

8
CAPITAL ALLOCATION
DELIVERING STRONG CAPITAL RETURNS THROUGH EFFICIENT CAPITAL DEPLOYMENT
STRATEGY
– Our multi-year capital deployment plan follows a disciplined and opportunistic approach, subject to market conditions
– In fiscal 2024, we deployed approximately $691.7 million:
– $253.4 million through quarterly dividends;
– $415.0 million through share repurchases; and
– $23.3 million through strategic investments
– The Board authorized a dividend of $0.51 per share payable on June 28, 2024 to stockholders of record on June 13, 2024
– Increased total share repurchase authorization capacity by $525 million to ~$3 billion; ~$1 billion available
– Our capital allocation priorities remain: operating needs, quarterly dividend, strategic M&A, share repurchases, and debt repayment
HISTORICAL CAPITAL DEPLOYMENT ($ IN MILLIONS)(1)
QUARTERLY CAPITAL DEPLOYMENT ($ IN MILLIONS)(1)
$191.5 $179.5
$147.9
$164.2
$200.2
$62.5 	$63.0 	$62.1 	$61.7 	$66.6
$125.7 $112.4
$80.8 $94.5
$127.3
$3.2 $4.0
$5.0
$8.1
$6.2
Quarterly Dividends 	Share Repurchases 	M&A
4Q23 	1Q24 	2Q24 	3Q24 	4Q24
$571.3
$1,493.9
$905.0
$691.7
$181.1 	$209.1 	$235.7 	$253.4
$318.1 $419.3 $224.0
$415.0
$72.2
$865.5
$445.3 	$23.3
Quarterly Dividends 	Share Repurchases 	M&A
FY21 	FY22 	FY23 	FY24
(3)
(1) Totals may not sum due to rounding.
(2) Includes share repurchases transacted but not settled and paid.
(3) Represents payments for strategic investments, net of cash acquired.
(2) (3) (2)

-- 8 of 17 --

9
FINANCIAL OUTLOOK
FULL YEAR FISCAL 2025 GUIDANCE(1)
OPERATING PERFORMANCE Fiscal Year 2025
Revenue Growth 8.0% – 11.0%
Adjusted EBITDA $1,260 – $1,300 million
Adjusted EBITDA Margin on Revenue ~11%
Adjusted Diluted EPS $5.80 – $6.05
Net Cash Provided by Operating Activities $825 – $925 million
(1) Reconciliations omitted in reliance on Item 10(e)(1)(i)(B) of Regulation S-K. See "Disclaimer."
KEY ASSUMPTIONS Fiscal Year 2025
Adjusted Effective Tax Rate 23% – 25%
Average Diluted Shares Outstanding 129 – 131 million
Interest Expense $180 – $190 million
Depreciation and Amortization ~$160 million
Cash Taxes Related to Section 174 ~$100 million
Capital Expenditures ~$100 million

-- 9 of 17 --

10
APPENDIX

-- 10 of 17 --

11
NON-GAAP FINANCIAL INFORMATION
• “Revenue, Excluding Billable Expenses” represents revenue less billable expenses. Booz Allen uses Revenue, Excluding Billable Expenses because it
provides management useful information about the Company’s operating performance by excluding the impact of costs that are not indicative of the level
of productivity of its client staff headcount and its overall direct labor, which management believes provides useful information to its investors about its
core operations.
• “Adjusted Operating Income” represents operating income before the change in provision for claimed indirect costs, acquisition and divestiture costs,
financing transaction costs, significant acquisition amortization, DC tax assessment adjustment, and the reserve associated with the U.S. Department of
Justice investigation disclosed in Note 20 to the Consolidated Financial Statements in the Company's Form 10-K for the fiscal year ended March 31, 2024.
Booz Allen prepares Adjusted Operating Income to eliminate the impact of items it does not consider indicative of ongoing operating performance due to
their inherent unusual, extraordinary or non-recurring nature or because they result from an event of a similar nature.
• “Adjusted EBITDA” represents net income (loss) attributable to common stockholders before income taxes, net interest and other expense and
depreciation and amortization and before certain other items, including the change in provision for claimed indirect costs, acquisition and divestiture
costs, financing transaction costs, DC tax assessment adjustment, and the reserve associated with the U.S. Department of Justice investigation disclosed in
Note 20 to the Consolidated Financial Statements in the Company's Form 10-K for the fiscal year ended March 31, 2024. “Adjusted EBITDA Margin on
Revenue” is calculated as Adjusted EBITDA divided by revenue. “Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses” is calculated as
Adjusted EBITDA divided by Revenue, Excluding Billable Expenses. Booz Allen prepares Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, and
Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses to eliminate the impact of items it does not consider indicative of ongoing operating
performance due to their inherent unusual, extraordinary or non-recurring nature or because they result from an event of a similar nature.
• “Adjusted Net Income” represents net income (loss) attributable to common stockholders before: (i) the change in provision for claimed indirect costs, (ii)
acquisition and divestiture costs, (iii) financing transaction costs, (iv) significant acquisition amortization, (v) DC tax assessment adjustment, (vi) the
reserve associated with the U.S. Department of Justice investigation disclosed in Note 20 to the Consolidated Financial Statements in the Company's Form
10-K for the fiscal year ended March 31, 2024, (vii) valuation adjustments to cost method investments, (viii) gains associated with divestitures or
deconsolidation, and (iv) amortization and write-off of debt issuance costs and debt discount, in each case net of the tax effect where appropriate
calculated using an assumed effective tax rate. Booz Allen prepares Adjusted Net Income to eliminate the impact of items, net of tax, it does not consider
indicative of ongoing operating performance due to their inherent unusual, extraordinary or non-recurring nature or because they result from an event of
a similar nature. Booz Allen views Adjusted Net Income as an important indicator of performance consistent with the manner in which management
measures and forecasts the Company's performance and the way in which management is incentivized to perform.
• “Adjusted Diluted EPS” represents diluted EPS calculated using Adjusted Net Income as opposed to net income. Additionally, Adjusted Diluted EPS does
not contemplate any adjustments to net income as required under the two-class method as disclosed in the footnotes to the consolidated financial
statements of the Company's Form 10-K for the fiscal year ended March 31, 2024.
• "Free Cash Flow" represents the net cash generated from operating activities less the impact of purchases of property, equipment and software. "Free
Cash Flow Conversion" is calculated as Free Cash Flow divided by Adjusted Net Income.
• "Adjusted Effective Tax Rate" represents income tax expense (benefit) excluding the income tax effects of adjustments to net income, divided by adjusted
earnings before income tax expense.
• "Net Leverage Ratio" is calculated as net debt (total debt less cash) divided by Adjusted EBITDA over the prior twelve months.

-- 11 of 17 --

12
NON-GAAP FINANCIAL INFORMATION (Unaudited)
Three Months Ended
March 31, Fiscal Year Ended
March 31,
(In thousands, except share and per share data) 2024 2023 2024 2023
Revenue, Excluding Billable Expenses
Revenue $ 2,771,327 $ 2,433,261 $ 10,661,896 $ 9,258,911
Less: Billable expenses 844,788 739,124 3,281,776 2,808,857
Revenue, Excluding Billable Expenses* $ 1,926,539 $ 1,694,137 $ 7,380,120 $ 6,450,054
Adjusted Operating Income
Operating Income (loss) $ 264,439 $ (42,908) $ 1,013,403 $ 446,848
Change in provision for claimed indirect costs (a) — — (18,345) —
Acquisition and divestiture costs (b) 2,100 4,148 7,580 44,269
Financing transaction costs (c) — — 820 6,888
Significant acquisition amortization (d) 13,596 15,278 53,897 51,553
DC tax assessment adjustment (e) (20,050) — (20,050) —
Legal matter reserve (f) — 226,000 27,453 350,000
Adjusted Operating Income $ 260,085 $ 202,518 $ 1,064,758 $ 899,558
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue & Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses
Net income (loss) attributable to common stockholders $ 127,955 $ (68,422) $ 605,706 $ 271,791
Income tax expense (benefit) 91,323 (6,552) 247,614 96,734
Interest and other, net (g) 45,161 31,992 160,083 78,899
Depreciation and amortization 40,335 44,284 164,203 165,484
EBITDA 304,774 1,302 1,177,606 612,908
Change in provision for claimed indirect costs (a) — — (18,345) —
Acquisition and divestiture costs (b) 2,100 4,148 7,580 44,269
Financing transaction costs (c) — — 820 6,888
DC tax assessment adjustment (e) (20,050) — (20,050) —
Legal matter reserve (f) — 226,000 27,453 350,000
Adjusted EBITDA $ 286,824 $ 231,450 $ 1,175,064 $ 1,014,065
Net income margin attributable to common stockholders 4.6 % (2.8) % 5.7 % 2.9 %
Adjusted EBITDA Margin on Revenue 10.3 % 9.5 % 11.0 % 11.0 %
Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses 14.9 % 13.7 % 15.9 % 15.7 %
12
*Revenue, Excluding Billable Expenses includes $18.3 million of revenue resulting from the reduction to our provision for claimed indirect costs (see note a below), and $20.0 million of
revenue resulting from the impact of the Company's unfavorable ruling from the District of Columbia Court of Appeals (see note e below).

-- 12 of 17 --

13
NON-GAAP FINANCIAL INFORMATION (Unaudited)
Three Months Ended
March 31, Fiscal Year Ended
March 31,
Adjusted Net Income
Net income attributable to common stockholders $ 127,955 $ (68,422) $ 605,706 $ 271,791
Change in provision for claimed indirect costs (a) — — (18,345) —
Acquisition and divestiture costs (b) 2,100 4,148 7,580 44,269
Financing transaction costs (c) — — 820 6,888
Significant acquisition amortization (d) 13,596 15,278 53,897 51,553
DC tax assessment adjustment (e) (20,050) — (20,050) —
Legal matter reserve (f) — 226,000 27,453 350,000
Valuation adjustment to cost method investments (h) 5,669 — 5,669 —
Gains associated with divestitures or deconsolidation (i) — — — (44,632)
Amortization or write-off of debt issuance costs and debt discount 1,067 774 4,017 6,554
Adjustments for tax effect (j) 42,124 (43,871) 52,218 (81,389)
Adjusted Net Income $ 172,461 $ 133,907 $ 718,965 $ 605,034
Adjusted Diluted Earnings Per Share
Weighted-average number of diluted shares outstanding $ 130,040,939 $ 132,364,339 $ 130,815,903 $ 132,716,436
Diluted earnings per share $ 0.98 $ (0.52) $ 4.59 $ 2.03
Adjusted Net Income Per Diluted Share (k) $ 1.33 $ 1.01 $ 5.50 $ 4.56
Free Cash Flow
Net cash provided by operating activities 143,770 237,148 258,838 602,822
Less: Purchases of property, equipment and software (16,167) (24,732) (66,699) (76,130)
Free Cash Flow $ 127,603 $ 212,416 $ 192,139 $ 526,692
Operating cash flow conversion 112 % (347) % 43 % 222 %
Free cash flow conversion 74 % 159 % 27 % 87 %
13

-- 13 of 17 --

14
NON-GAAP FINANCIAL INFORMATION (Unaudited)
(a) Represents the reduction to our provision for claimed indirect costs recorded during the second quarter of fiscal 2024, which resulted in a
corresponding increase to revenue, as a result of the Defense Contract Audit Agency's findings related to its audit of our claimed indirect costs for fiscal
2022. See Note 20, “Commitments and Contingencies,” to the consolidated financial statements in the Company's Form 10-K for the fiscal year ended
March 31, 2024 for further information.
(b)Represents costs associated with the acquisition efforts of the Company related to transactions for which the Company has entered into a letter of
intent to acquire a controlling financial interest in the target entity, as well as the divestiture costs incurred in divesting a portion of our business.
Acquisition and divestiture costs primarily include costs associated with (i) buy-side and sell-side due diligence activities, (ii) compensation expenses
associated with employee retention, and (iii) legal and advisory fees, primarily associated with the acquisitions of Liberty IT Solutions, LLC (“Liberty”) and
Tracepoint Holdings, LLC (“Tracepoint”) in fiscal 2022, and the acquisition of EverWatch Corp. (“EverWatch”) and the divestitures of our management
consulting business serving the Middle East and North Africa (“MENA”) and our Managed Threat Services business (“MTS”) in fiscal 2023. See Note 5,
“Acquisition and Divestitures,” to the consolidated financial statements in the Company's Form 10-K for the fiscal year ended March 31, 2024 for further
information.
(c) Reflects expenses associated with debt financing activities incurred during the second quarters of fiscal 2024 and 2023.
(d) Amortization expense associated with acquired intangibles from significant acquisitions. Significant acquisitions include acquisitions which the
Company considers to be beyond the scope of our normal operations. Significant acquisition amortization includes amortization expense associated with
the acquisition of Liberty in the second quarter of fiscal 2022 and EverWatch in the third quarter of fiscal 2023.
(e) Reflects the impact (specifically the revenue from recoverable expenses) of the Company's unfavorable ruling from the District of Columbia Court of
Appeals related to contested tax assessments from the District of Columbia Office of Tax and Revenue (“DC OTR”). See Note 13, “Income Taxes,”to the
consolidated financial statements in the Company's Form 10-K for the fiscal year ended March 31, 2024 for further information.
(f) Reserve associated with the U.S. Department of Justice's investigation of the Company. See Note 20, “Commitments and Contingencies,”to the
consolidated financial statements in the Company's Form 10-K for the fiscal year ended March 31, 2024 for further information.
(g) Reflects the combination of Interest expense and Other income, net from the consolidated statement of operations.
(h) Represents non-recurring valuation adjustments to the Company's cost method investments, primarily the write-off of one of its investments.
(i) Represents the gain recognized on the divestitures of the Company's MENA business in the second quarter of fiscal 2023, its MTS business in the third
quarter of fiscal 2023, and the gain on the deconsolidation of an artificial intelligence software platform business in the third quarter of fiscal 2023.
(j) Reflects the tax effect of adjustments at an assumed effective tax rate of 26%, which approximates the blended federal and state tax rates, and
consistently excludes the impact of other tax credits and incentive benefits realized. The tax effect of certain discrete items is calculated specifically and
may vary from the general 26% rate. The tax effect also includes the indirect effects of uncertainty around the application of Section 174 of the Tax Cuts
and Jobs Act of 2017 ($(22.0) million for fiscal 2024, and $22.0 million for fiscal 2023), and the impact of the Company's unfavorable ruling from the
District of Columbia Court of Appeals related to contested tax assessments from the DC OTR ($42.7 million for the three and twelve months ended March
31, 2024, respectively). See Note 13, “Income Taxes,”
(k) Excludes adjustments of approximately $1.1 million and $5.0 million of net earnings for the three and twelve months ended March 31, 2024,
respectively, and approximately $0.5 million and $2.1 million of net earnings for the three and twelve months ended March 31, 2023, respectively,
associated with the application of the two-class method for computing diluted earnings per share.
14

-- 14 of 17 --

15
NON-GAAP FINANCIAL INFORMATION (Unaudited)
(In thousands, except share and per share data) Three Months Ended
March 31, 2024 Three Months Ended
December 31, 2023 Three Months Ended
September 30, 2023 Three Months Ended
June 30, 2023
Net income attributable to common stockholders $ 127,955 $ 145,644 $ 170,718 $ 161,388
Income tax expense 91,323 61,740 55,071 39,480
Interest and other, net (a) 45,161 40,174 41,200 33,550
Depreciation and amortization 40,335 41,113 40,907 41,847
EBITDA $ 304,774 $ 288,671 $ 307,896 $ 276,265
Change in provision for claimed indirect costs (b) — — (18,345) —
Acquisition and divestiture costs (c) 2,100 1,952 260 3,268
Financing transaction costs (d) — — 820 —
DC tax assessment adjustment (e) (20,050) — — —
Legal matter reserve (f) — — — 27,453
Adjusted EBITDA $ 286,824 $ 290,623 $ 290,631 $ 306,986
Last 12 months Adjusted EBITDA $ 1,175,064
Total Debt $ 3,411,816
Less: Cash 554,257
Net Debt $ 2,857,559
Net Leverage Ratio (g) 2.4
Three Months Ended
March 31, 2023 Three Months Ended
December 31, 2022 Three Months Ended
September 30, 2022 Three Months Ended
June 30, 2022
Net income (loss) attributable to common
stockholders $ (68,422) $ 30,997 $ 170,932 $ 138,284
Income tax (benefit) expense (6,552) 10,539 51,258 41,489
Interest and other, net (a) 31,992 17,412 1,882 27,613
Depreciation and amortization 44,284 42,046 39,052 40,102
EBITDA $ 1,302 $ 100,994 $ 263,124 $ 247,488
Acquisition and divestiture costs (c) 4,148 19,096 15,932 5,093
Financing transaction costs (d) — — 6,888 —
Legal matter reserve (e) 226,000 — — —
Adjusted EBITDA $ 231,450 $ 244,090 $ 285,944 $ 252,581
Last 12 months Adjusted EBITDA $ 1,014,065
Total Debt $ 2,812,145
Less: Cash 404,862
Net Debt $ 2,407,283
Net Leverage Ratio (g) 2.4 15
(a) Reflects the combination of Interest expense and
Other income, net from the consolidated statement
of operations.
(b) Represents the reduction to our provision for
claimed indirect costs recorded during the second
quarter of fiscal 2024, which resulted in a
corresponding increase to revenue, as a result of the
Defense Contract Audit Agency's findings related to
its audit of our claimed indirect costs for fiscal 2022.
See Note 20, “Commitments and Contingencies,” to
the consolidated financial statements in the
Company's Form 10-K for the fiscal year ended March
31, 2024 for further information.
(c) Represents costs associated with the acquisition
efforts of the Company related to transactions for
which the Company has entered into a letter of intent
to acquire a controlling financial interest in the target
entity, as well as the divestiture costs incurred in
divesting a portion of our business. Acquisition and
divestiture costs primarily include costs associated
with (i) buy-side and sell-side due diligence activities,
(ii) compensation expenses associated with employee
retention, and (iii) legal and advisory fees, primarily
associated with the acquisitions of Liberty IT
Solutions, LLC (“Liberty”) and Tracepoint Holdings,
LLC (“Tracepoint”) in fiscal 2022, and the acquisition
of EverWatch Corp. (“EverWatch”) and the
divestitures of our management consulting business
serving the Middle East and North Africa (“MENA”)
and our Managed Threat Services business (“MTS”)
in fiscal 2023. See Note 5, “Acquisition and
Divestitures,” to the consolidated financial
statements in the Company's From 10-K for the fiscal
year ended March 31, 2024 for further information.
(d) Reflects expenses associated with debt financing
activities incurred during the second quarters of fiscal
2024 and 2023.
(e) Reflects the impact (specifically the revenue from
recoverable expenses) of the Company's unfavorable
ruling from the District of Columbia Court of Appeals
related to contested tax assessments from the
District of Columbia Office of Tax and Revenue (“DC
OTR”). See Note 13, “Income Taxes,”to the
consolidated financial statements in the Company's
From 10-K for the fiscal year ended March 31, 2024
for further information.
(f)Reserve associated with the U.S. Department of
Justice's investigation of the Company. See Note 20,
“Commitments and Contingencies,”
(g) "Net Leverage Ratio" is calculated as net debt
(total debt less cash) divided by Adjusted EBITDA
over the prior twelve months.

-- 15 of 17 --

16
FINANCIAL RESULTS – KEY DRIVERS
Fourth Quarter Fiscal 2024 – Below is a summary of the key factors driving results for the fiscal 2024 fourth quarter ended March 31, 2024
as compared to the prior year period:
• Revenue increased 13.9% to $2.8 billion and Revenue, Excluding Billable Expenses increased 13.7% to $1.9 billion. Revenue growth
was primarily driven by strong demand for our services and solutions as well as an increase in headcount to meet that demand.
• Operating income (loss) increased to $264.4 million from $(42.9) million, and Adjusted Operating Income increased to $260.1 million
from $202.5 million. The increase was primarily driven by the same drivers benefiting revenue growth as well as strong contract-level
performance coupled with ongoing cost management efforts. In addition, fiscal 2023 operating income (loss) was negatively impacted
by a $226.0 million reserve associated with the U.S. Department of Justice's investigation of the Company recorded in the fourth
quarter. The increase in Adjusted Operating Income was driven by the same factors impacting operating income (loss) with the
exception of the aforementioned legal matter reserve, which did not impact Adjusted Operating Income.
• Net income (loss) and net income (loss) attributable to common stockholders both increased to $128.0 million from $(68.3) million
and $(68.4) million, respectively. Adjusted Net Income increased to $172.5 million from $133.9 million . These changes were
primarily driven by the same factors as operating income and Adjusted Operating Income. An increase in income tax expense,
primarily as a result of increases in state taxes related to an unfavorable ruling received from the District of Columbia Court of
Appeals related to contested tax assessments from the District of Columbia Office of Tax and Revenue (“DC OTR”), also had an
unfavorable impact on net income. Net income (loss) and Adjusted Net Income were also affected by higher interest expense.
• EBITDA increased to $304.8 million from $1.3 million and Adjusted EBITDA increased to $286.8 million from $231.5 million.These
changes were due to the same factors as operating income and Adjusted Operating Income, respectively.
• Diluted EPS increased to $0.98 from $(0.52) and Adjusted Diluted EPS increased to $1.33 from $1.01. The changes were primarily
driven by the same factors as net income and Adjusted Net Income, respectively, as well as a lower share count in the fourth quarter
of fiscal 2024.

-- 16 of 17 --

17
FINANCIAL RESULTS – KEY DRIVERS
Fiscal year ended March 31, 2024 – Below is a summary of the key factors driving results for the fiscal year 2024 ended March 31, 2024 as
compared to the prior year:
• Revenue increased 15.2% to $10.7 billion and Revenue, Excluding Billable Expenses increased 14.4% to $7.4 billion. Revenue growth
was primarily driven by strong demand for our services and solutions as well as an increase in headcount to meet that demand.
• Operating income increased to $1,013.4 million from $446.8 million, and Adjusted Operating Income increased to $1,064.8 million
from $899.6 million. The increase was primarily driven by the same drivers benefiting revenue growth as well as strong contract-level
performance coupled with ongoing cost management efforts. In addition, fiscal 2023 operating income was negatively impacted by a
$350.0 million reserve associated with the U.S. Department of Justice's investigation of the Company. The increase in Adjusted
Operating Income was driven by the same factors impacting Operating Income with the exception of the aforementioned legal matter
reserve, which did not impact Adjusted Operating Income.
• Net income and net income attributable to common stockholders both increased to $605.7 million from $271.2 million and $271.8
million, respectively. Adjusted Net income increased to $719.0 million from $605.0 million. These changes were primarily driven by the
same factors as operating income and Adjusted Operating Income. Net income in the prior year was affected by a $31.2 million pre-
tax gain from the divestiture of the Company's MENA business, an $8.9 million pre-tax gain from the de-consolidation of an artificial
intelligence software platform business, and a $4.6 million pre-tax gain associated with the divestiture of the Company's Managed
Threat Services business. In addition, an increase in the provision for income taxes associated with the reversal of an uncertain tax
position related to Section 174 of the Tax Cuts and Jobs Act of 2017 had a negative impact on net income, as well as increases in
state taxes related to an unfavorable ruling received from the District of Columbia Court of Appeals related to contested tax
assessments from the DC OTR. Net income and Adjusted Net Income were also affected by higher interest expense.
• EBITDA increased to $1,177.6 million from $612.9 million and Adjusted EBITDA increased to $1,175.1 million from $1,014.1 million
These changes were due to the same factors as operating income and Adjusted Operating Income, respectively.
• Diluted EPS increased to $4.59 from $2.03 and Adjusted Diluted EPS increased to 5.50 from 4.56. The changes were primarily driven
by the same factors as Net Income and Adjusted Net Income, respectively, as well as a lower share count in fiscal 2024.
• Net cash provided by operating activities was $258.8 million for the fiscal year ended March 31, 2024, as compared to $602.8 million
in the prior year. Free Cash Flow was $192.1 million for the fiscal year ended March 31, 2024, as compared to $526.7 million in the
prior year. Fiscal 2024 operating cash was aided by strong collection performance and overall revenue growth but was impacted by a
$377.5 million outflow related to the U.S. Department of Justice matter noted above.

-- 17 of 17 --